In this issue of Cell Stem Cell, Warren et al. (2010) describe a new methodology, using synthetic mRNA, for efficiently generating iPSCs without compromising genomic integrity. This powerful approach can also be used for directed differentiation of iPSCs, or even for trans-differentiation to generate clinically relevant differentiated cell types.
Copyright © 2010 Elsevier Inc. All rights reserved.